Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
08/2003
08/14/2003US20030153740 Cloning libraries with probe which comprises hepatitis B virus (HBV); hap proteins
08/14/2003US20030153738 Homologs of bacterial AlkB gene (hABH); receptor binding assay; for repairing alkylated DNA, preventing/treating cell death/cancer
08/14/2003US20030153734 Via chromatography of immobilized tissue extracts through molecular sieves; animal models; amyloid precursor proteins
08/14/2003US20030153733 Antibiotic resistant drug screening; vaccines
08/14/2003US20030153732 Novel polypepetide
08/14/2003US20030153731 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
08/14/2003US20030153730 Autotaxin: motility stimulating protein useful in cancer diagnosis and therapy
08/14/2003US20030153727 Controlling protein levels in eucaryotic organisms
08/14/2003US20030153615 Novel compositions and uses of dictyostatin compounds
08/14/2003US20030153525 Identifies differential expression of 1465, 1587, 2146, 2207, 32838, 336 OR 52908 genes in tissues relating to pain sensation relative to their expression in normal or non-painful disease states
08/14/2003US20030153524 Including extracellular matrix production and/or deposition, neovascularization, inflammation, cell proliferation, cell migration, associated with connective tissue growth factor by administering agent that decreases expression of the factor
08/14/2003US20030153522 Rat pituitary tumor transforming gene (PTTG) carboxy-terminal peptides and methods of use thereof to inhibit neoplastic cellular proliferation and/or transformation
08/14/2003US20030153520 Inside cells, such as those involving fusion events and in particular those involving exocytic events, in particular relates to positive and negative regulation of any tetanus neurotoxin (TeNT)-resistant pathway inside a cell
08/14/2003US20030153518 Activation and inhibition of the immune system
08/14/2003US20030153516 Methods and materials for treating and preventing inflammation of mucosal tissue
08/14/2003US20030153504 Antiinflammatory agents selects from a group of tetrapeptides, hexapeptides, octapeptides, oligopeptides, polypeptides
08/14/2003US20030153503 Therapeutic treatment of hypoxia, anemia, and enzyme inhibitors; antihypoxic agents
08/14/2003US20030153502 A water-soluble polypeptide having hydrophobic side chains, for use as bactericides treating infections, detoxification of endotoxin, cell antiproliferative agents, antagonist of tumor necrosis factor
08/14/2003US20030153499 Isolated nucleic acid molecules encoding polypeptides; genetic engineering antiproliferative agents for regulating cell differentiation, immunomodulators
08/14/2003US20030153498 An isolated polynucleotide encoding the polypeptide, treating infections, viral diseases, anorexia, bulimia, asthma, Parkinson's diseases, hypotension, hypertension, cancers, osteoporosis, angina pectoris, cardiovascular disorders
08/14/2003US20030153497 A polypeptides and polynucleotides encoding the polypeptides, for obesity, insulin resistance, type 2 diabetes, cachexia
08/14/2003US20030153495 Treatment of inflammatory bowel disease using growth factors
08/14/2003US20030153494 Somatostatin agonist; for binding one or more of human somatostatin subtype receptors -1, -2, -3 and -5; treating diseases such as Cushings Syndrome, gonadotropinoma, hyperparathyroidism, Paget's disease
08/14/2003US20030153492 Novel glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof
08/14/2003US20030153490 Insulin conjugates and methods of use thereof
08/14/2003US20030153489 Agent for preventing and/or treating multiple organ failure
08/14/2003US20030153097 Modulation of COP9 signalsome isopeptidase activity
08/14/2003US20030153081 Viral core protein-cationic lipid-nucleic acid-delivery complexes
08/14/2003US20030153072 Culturing spermatogonial stem cells in the presence of BMP8 (bone morphogenetic protein-8) or a biologically active fragment or an agonist to effect proliferation of mammal spermatogonial stem cells
08/14/2003US20030153066 Isolating nucleic acid putatively encoding the viral gene from the viral genome; programming a cell-free translation system with such nucleic acid, determine if capsid assembly has occurred which indicates that viral gene is required
08/14/2003US20030153063 Polypeptides; membrane proteins for diagonsis, prevention and treatment of cardiovascular disorders
08/14/2003US20030153060 Cytochrome P450 monooxygenase and NADPH cytochrome P450 oxidoreductase genes and proteins related to the omega hydroxylase complex of Candida tropicalis and methods relating thereto
08/14/2003US20030153050 Cytokines
08/14/2003US20030153049 Genetic engineered plasmid vectors; antibiotic resistance; anticancer agents
08/14/2003US20030153048 Novel proteins and methods for producing the proteins
08/14/2003US20030153047 AIB1, a novel steroid receptor co-activator
08/14/2003US20030153046 Interferon gamma conjugates
08/14/2003US20030153045 Methods and compositions for protein expression and purification
08/14/2003US20030153043 Method for the production of non-immunogenic proteins
08/14/2003US20030153041 Controlling calcium channel blockers; central nervous system disorders, gastrointestinal disorders, cardiovascular disorders, muscular disorders
08/14/2003US20030153040 Central nervous system disorders; antiinflammatory agents; antidiabetic agents; anticancer agents; hybrid polynucleotide
08/14/2003US20030153037 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153036 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153035 Isolated nucleic acids; human or veterinary medicine
08/14/2003US20030153034 Genetic engineering; stimulant for lymphocyte cell differentiation
08/14/2003US20030153033 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030153029 Extraction from mammals skins; culturing; therapy for asthma, antiallergens
08/14/2003US20030153026 Mutant binding protein containing reporter molecules; monitoring glucose concentration; quantitative analysis
08/14/2003US20030153016 PSCA: prostate stem cell antigen
08/14/2003US20030153004 Learning enhancement, cognition activators, sleep disorders, psychological disorders; screening Dna which codes serotonin receptor
08/14/2003US20030153003 Growth hormone variants
08/14/2003US20030153002 Ribosome structure and protein synthesis inhibitors
08/14/2003US20030153000 Genetic engineering; culture product; recovering
08/14/2003US20030152999 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152991 Transduction of protein
08/14/2003US20030152989 Genetic engineering; therapy for liver disease; antitumor agents
08/14/2003US20030152977 Which is highly expressed in brain, spinal cord and pituitary, for analyzing neuological systems and conditions; membrane proteins
08/14/2003US20030152975 Screening for genes which trigger hypersensitive response in tobacco plants in presence of ubiquitous Phytophthora infestans elicitor; horticulture
08/14/2003US20030152973 G-protein coupled receptor org3
08/14/2003US20030152965 HCV core protein sequences
08/14/2003US20030152963 Comprises peroxisome proliferator activated receptors; for treating accompanying conditions such as obesity, retinal degeneration, and disorders affecting the nervous system, heart, and/or kidneys
08/14/2003US20030152954 NPHS2 gene involved in the steroid-resistant nephrotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
08/14/2003US20030152953 Polynucleotide encoding a novel human potassium channel alpha-subunit, K+alphaM2
08/14/2003US20030152948 Methods for the simultaneous detection of HCV antigens and HCV antibodies
08/14/2003US20030152946 Bh4-fused polypeptides
08/14/2003US20030152945 Drosophila gene mutations (open reading frames) disrupt mitosis and/or meiosis
08/14/2003US20030152941 Nucleic acids encoding novel von Willebrand/Thrombospondin factor-like polypeptides and uses of same
08/14/2003US20030152940 Vectors comprise avian lysozyme leader peptide for targetting the endoplasmic reticulum; heparin affinity chromatography
08/14/2003US20030152939 Novel secreted proteins and polynucleotides encoding them
08/14/2003US20030152935 Comprises hybridization probes; electrophoresis; drug screening
08/14/2003US20030152933 Which are capable of being directed to the endoplasmic reticulum, secretory vesicles, or the extracellular space as a result of a signal sequence; medical diagnosis
08/14/2003US20030152922 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/14/2003US20030152921 Full-length human cDNAs encoding potentially secreted proteins
08/14/2003US20030152592 Genetic engineering hybrid protein
08/14/2003US20030152590 Virion protein; induce immunology response; genetic engineered Dna
08/14/2003US20030152584 Abundant extracellular products and methods for their production and use
08/14/2003US20030152583 Dna which codes complex
08/14/2003US20030152582 CTL epitopes from EBV
08/14/2003US20030152581 Compound and method for the prevention and/or the treatment of allergy
08/14/2003US20030152580 Induce immunology response; viricides, anticancer agents
08/14/2003US20030152579 Controlling biosynthesis of hybrid protein; therapy against Helicobacter infections
08/14/2003US20030152576 Antiinflammatory agents; hepatitis virus; vaccines
08/14/2003US20030152573 Anticancer, antitumor agents
08/14/2003US20030152567 Protease for activating clotting factor VII
08/14/2003US20030152564 Anti-inflammatory peptides derived from C-reactive protein
08/14/2003US20030152560 Therapy for Fabry's disease; genetic engineering; cloning; gene therapy
08/14/2003US20030152557 Methods for inhibiting histone deacetylase-4
08/14/2003US20030152553 Transfection, transduction of cells
08/14/2003US20030152526 Bovine milk growth factor
08/14/2003CA2485064A1 Albumin-fused kunitz domain peptides
08/14/2003CA2476214A1 Proliferated cell lines and uses thereof
08/14/2003CA2476006A1 Egf/egfr complex
08/14/2003CA2475539A1 Hiv inhibiting proteins
08/14/2003CA2475446A1 Viral variants with altered susceptibility to nucleoside analogs and uses thereof
08/14/2003CA2475382A1 Albumin-fused anti-angiogenesis peptides
08/14/2003CA2475326A1 A continuous cell line for the production of vaccines
08/14/2003CA2475276A1 Zinc finger libraries
08/14/2003CA2475273A1 Modified pituitary gland development in offspring from expectant mother animals treated with growth hormone releasing hormone therapy
08/14/2003CA2475247A1 Anti-pathogen treatments
08/14/2003CA2475235A1 Production process of recombinant placental growth factor
1 ... 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 1566 1567 1568 1569 1570 1571 1572 1573 ... 2916